Neue Suche | Kongressdetail
Druckansicht
 
 

Gene Therapy for Muscular Disorders

Evvnt Promotion / evvnt
-
25.05.2021 - 27.05.2021  Online
Time: 08:00 to 17:00
 
Kongressthemen
With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers targeting the muscle when it comes to optimizing delivery and navigating toxicity to develop truly safe and transformative therapeutics for muscular disorders patients.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/727634-0?pid=4832

Speakers: Michael O'Callaghan, Senior Vice President, Translational Medicine, AskBio, Michael Roberts, Chief Technology Officer, AskBio Europe, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/727634-1?pid=4832
Herr Ellie Saunders
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 1199.00 to USD 2696.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

European Public Health Association (EUPHA)Ärzte der WeltnewTreeHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrztekammer für Wien